The Valley Desk

NCT06272487 · Interventional trial

Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

Overall registry status Completed

Phase 2

Conditions High Cardiovascular Risk, Hypertension

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov